We are updating our Privacy Policy and Terms and Conditions to help you clearly understand how your personal information is collected, stored and managed. Learn More
Menu Back toPAREXEL-International-Innovation-Theater-7151908

DIA 2018 Global Annual Meeting

The DIA 2018 Global Annual Meeting brings together thousands of innovators from around the globe.

PAREXEL International Innovation Theater: The Innovation Imperative: The Future of Drug Development

    Session Chair(s)
        PAREXEL International

      PAREXEL International

      • United States
    The Economist Intelligence Unit will unveil its independent research findings titled, “The Innovation Imperative: The Future of Drug Development.” Commissioned by PAREXEL, the report shows how four key innovations consistently improve industry success metrics such as enrollment rates, regulatory approval, and payer adoption. However, despite their quantifiable positive impact, their adoption appears low. The reasons for this “adoption lag” and potential solutions will be discussed.
      Alberto  Grignolo, DIAFellow, PhD

      Alberto Grignolo, DIAFellow, PhD

      • Corporate VP PAREXEL Consulting
      • PAREXEL, United States
      David  Humphreys

      David Humphreys

      • Head of Health Policy, EIU Healthcare
      • The Economist Intelligence Unit, United States